The goal of newborn screening programs is to detect and start treatment within the first 1–2 weeks of life. Treatment consists of a daily dose of thyroxine, available as a small tablet. The generic name is levothyroxine, and several brands are available. The tablet is crushed and given to the baby with a small amount of water or milk. The most commonly recommended dose range is 10-15 μg/kg daily, typically 12.5 to 37.5 or 44 μg. Within a few weeks, the T4 and TSH levels are rechecked to confirm that they are being normalized by treatment. As the<unk> ild grows up, these levels are<unk> ecked regularly to maintain the right dose. The dose increases as the<unk> ild grow.
Congenital hypothyroidism
Congenital iodine deficiency syndrome
Congenital adrenal hyperplasia
Thyroid dysgenesis
Late onset congenital adrenal hyperplasia
Lipoid congenital adrenal hyperplasia
Congenital hyperinsulinism
Isolated growth hormone deficiency